SLC5A2 and type 2 diabetes mellitus: In another study with a T2DM mouse model, SGLT2 inhibitors improved albuminuria, glomerular hyperfiltration, and mesangial matrix expansion via an improvement in oxidative stress in the glomerulus [73].